Federal Register of Legislation - Australian Government

Primary content

PB 84 of 2011 Determinations/Health as made
This Determination amends the National Health (Price and Special Patient Contribution) Determination 2010 (No. PB 109 of 2010) to make changes to both brands of pharmaceutical items that have a determined price and a claimed price and to the amount of the claimed price for certain brands of pharmaceutical items.
Administered by: Health
Registered 28 Nov 2011
Tabling HistoryDate
Tabled HR07-Feb-2012
Tabled Senate07-Feb-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

PB 84 of 2011

National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 8)1

National Health Act 1953

I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under section 85B of the National Health Act 1953.

Dated 22 November 2011

 

 

 

 

 

 

 

FELICITY McNEILL

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing


 


1          Name of Instrument

            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 8).

            (2)        This Instrument may also be cited as PB 84 of 2011.

2          Commencement

            This Instrument commences on 1 December 2011.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).



Schedule 1     Amendments

 

[1]       Schedule 1, entry for Alendronic Acid

omit from the column headed “Claimed Price”:          29.10     substitute:             29.53

[2]       Schedule 1, entry for Alendronic acid with colecalciferol

omit from the column headed “Form”:

equivalent to

[3]       Schedule 1, entry for Bleomycin

omit from the column headed “Form”:

(with any determined brand of sodium chloride injection as the required solvent)

[4]       Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 5 mg

omit from the column headed “Claimed Price”:          9.60        substitute:             9.89

[5]       Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg

omit from the column headed “Claimed Price”:          13.16     substitute:             13.45

[6]       Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg

omit from the column headed “Claimed Price”:          15.65     substitute:             15.94

[7]       Schedule 1, entry for Erythromycin in the form Capsule 250 mg (containing enteric coated pellets)

omit from the column headed “Claimed Price”:          3.60        substitute:             4.56

[8]       Schedule 1, entry for Erythromycin in the form Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL

(a)           omit from the column headed “Determined Price”:     2.78        substitute:             4.80

(b)           omit from the column headed “Claimed Price”:          5.15        substitute:             7.16


[9]       Schedule 1, entry for Erythromycin in the form Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL

(a)           omit from the column headed “Determined Price”:     3.68        substitute:             6.11

(b)           omit from the column headed “Claimed Price”:          6.06        substitute:             8.49

[10]     Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)

omit from the column headed “Claimed Price”:          15.46     substitute:             16.80

[11]     Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)

omit from the column headed “Claimed Price”:          16.82     substitute:             18.75

[12]     Schedule 1, entry for Hydrocortisone in the form Cream containing hydrocortisone acetate 10 mg per g, 50 g

omit:

 

 

Application

Cortef

1

1.86

1.93

[13]     Schedule 1, entry for Imipramine in the form Tablet containing imipramine hydrochloride 25 mg

(a)           omit from the column headed “Determined Price”:     1.84        substitute:             5.23

(b)           omit from the column headed “Claimed Price”:          4.27        substitute:             7.65

[14]     Schedule 1, entry for Indomethacin in the form Capsule 25 mg

(a)           omit from the column headed “Determined Price”:     2.34        substitute:             2.61

(b)           omit from the column headed “Claimed Price”:          3.23        substitute:             3.49

[15]     Schedule 1, entry for Lisinopril in the form Tablet 5 mg [Prinivil 5]

omit from the column headed “Claimed Price”:          9.63        substitute:             9.81

[16]     Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Prinivil 10]

omit from the column headed “Claimed Price”:          12.83     substitute:             12.99

[17]     Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Prinivil 20]

omit from the column headed “Claimed Price”:          15.30     substitute:             15.48


[18]     Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg

omit from the column headed “Claimed Price”:          10.59     substitute:             11.13

[19]     Schedule 1, entry for Meloxicam in the form Tablet 15 mg

omit from the column headed “Claimed Price”:          15.00     substitute:             15.54

[20]     Schedule 1, entry for Mianserin in the form Tablet containing mianserin hydrochloride 10 mg

omit from the column headed “Claimed Price”:          9.42        substitute:             10.66

[21]     Schedule 1, entry for Mianserin in the form Tablet containing mianserin hydrochloride 20 mg

omit from the column headed “Claimed Price”:          18.88     substitute:             19.32

[22]     Schedule 1, entry for Norethisterone with Ethinyloestradiol

substitute:

 

Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets

Oral

Brevinor

1

2.18

3.85

 

Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets

Oral

Brevinor-1

1

2.18

3.85

[23]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg

omit from the column headed “Determined Price”:     12.50     substitute:             12.41

[24]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg

omit from the column headed “Determined Price”:     19.89     substitute:             19.75

[25]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg

omit from the column headed “Determined Price”:     30.95     substitute:             30.60

[26]     Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg

omit from the column headed “Determined Price”:     47.58     substitute:             47.29

[27]     Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses
(CFC-free formulation)

omit from the column headed “Claimed Price”:          3.78        substitute:             4.23


[28]     Schedule 1, entry for Simvastatin in the form Tablet 5 mg

omit from the column headed “Claimed Price”:          14.02     substitute:             14.56

[29]     Schedule 1, entry for Simvastatin in the form Tablet 10 mg

omit from the column headed “Claimed Price” (twice occurring):          18.28     substitute:             18.82

[30]     Schedule 1, entry for Simvastatin in the form Tablet 20 mg

omit from the column headed “Claimed Price” (twice occurring):          25.01     substitute:             25.57

[31]     Schedule 1, entry for Simvastatin in the form Tablet 40 mg

omit from the column headed “Claimed Price” (twice occurring):          35.18     substitute:             35.80

[32]     Schedule 1, entry for Simvastatin in the form Tablet 80 mg

omit from the column headed “Claimed Price” (twice occurring):          48.79     substitute:             49.36

[33]     Schedule 1, entry for Sucralfate in the form Tablet equivalent to 1 g anhydrous sucralfate

(a)           omit from the column headed “Determined Price”:     14.72     substitute:             15.91

(b)           omit from the column headed “Claimed Price”:          16.51     substitute:             17.70

[34]     Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg

omit from the column headed “Claimed Price”:          10.78     substitute:             11.09

[35]     Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg

omit from the column headed “Claimed Price”:          20.83     substitute:             21.23

 

 

 

 

 

 

 

 

 

1Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.